GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) » Definitions » Gross-Profit-to-Asset %

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Shafa Darou Pharmaceutical Investment Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shafa Darou Pharmaceutical Investment Co's annualized Gross Profit for the quarter that ended in . 20 was IRR Mil. Shafa Darou Pharmaceutical Investment Co's average Total Assets over the quarter that ended in . 20 was IRR 0 Mil. Therefore, Shafa Darou Pharmaceutical Investment Co's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Shafa Darou Pharmaceutical Investment Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shafa Darou Pharmaceutical Investment Co Gross-Profit-to-Asset % Chart

Shafa Darou Pharmaceutical Investment Co Annual Data
Trend
Gross-Profit-to-Asset %

Shafa Darou Pharmaceutical Investment Co Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset % falls into.


Shafa Darou Pharmaceutical Investment Co Gross-Profit-to-Asset % Calculation

Shafa Darou Pharmaceutical Investment Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Shafa Darou Pharmaceutical Investment Co's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Shafa Darou Pharmaceutical Investment Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shafa Darou Pharmaceutical Investment Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
Traded in Other Exchanges
N/A
Address
Fakhar Moghadam Street, Dadman Street, No. 13, At the corner of East 4th Golbarg Alley, Shahrak-e Gharb, Tehran, IRN
Website
http://www.shafadarou.org
Shafa Darou Pharmaceutical Investment Co is a pharmaceutical holding company. Along with its subsidiaries it produces injectable, non-injectable, and antibiotics.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Headlines

No Headlines